Here is What the FDA is Saying About the COVID Vaccine
The COVID vaccine is a hot topic especially as we head into the winter months where many experts worry about the upcoming flu season crossing over with new COVID infections as we continue to reopen the nation.
The Food and Drug Administration has announced that although trial studies have completed multiple phases, they want to see at least sixty days of data from the last phases of trials before they will consider the approval of a COVID vaccine.
"The amount of data for an emergency vaccine is still hundreds of thousands of pages," says Peter Mark, MD, Ph.D., the FDA's Director of the Center for Biologics Evaluation and Research, offers in regard to why the FDA is asking for strict time guidelines after volunteers have taken the second COVID vaccination in recent trials.
It's a clinical trial many feel can not be rushed and statistics prove Americans are still skeptical of the vaccine itself, no matter when it becomes available.
In a report by Medicinenet.com, published in May of 2020 their survey indicated half of Americans would not get the vaccine even after FDA approval. Pew Research reported the same results in a survey they did just a few weeks ago.
Not surprisingly many Americans are leary of the development process for the vaccine, which the FDA is acutely aware of. "It’s only going to happen if people have confidence enough to go get vaccinated and we do have a crisis in vaccine confidence." Peter Mark recently acknowledged in a riveting Youtube interview you can view here.
The CDC recently published its presentation for workgroups who will have priority for the vaccine which includes "front-line medical workers, persons over the age of 65, and those with high-risk medical conditions" which adds further pressure of ensuring the COVID vaccine is safe.
The question then becomes, once approved by the FDA, will you be ready and willing to get the COVID vaccine as soon as it becomes available?